In the third episode, the Essentially Medicines crew interviews Dr. Monika Schneider, Managing Associate within the biomedical innovation team at the Duke-Margolis Center for Health Policy. Dr. Schneider, a research scientist by training, focuses on incentives for antimicrobial product development, value-based reimbursement policy and payment reform for medical products. She advocates for young students to be more involved with causes that they are passionate about